Search research articles
Contact Us
Filters
Showing results (381-390 of 394) with videos related to
Page
of 40
Sort By:
The British Journal of Ophthalmology
|
August 7, 2019
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study
Richard P Gale, Ian Pearce, Nicole Eter, et al.
Molecular Cancer Therapeutics
|
February 10, 2012
CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity
Joyce James, Bruce Ruggeri, Robert C Armstrong, et al.
British Journal of Haematology
|
April 19, 2017
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma
Peter Martin, Zhengming Chen, Bruce D Cheson, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
August 9, 2005
Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study
Constantine G Lyketsos, Leslie Toone, JoAnn Tschanz, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
September 2, 2018
Does the future of laparoscopic sleeve gastrectomy lie in the outpatient surgery center? A retrospective study of the safety of 3162 outpatient sleeve gastrectomies
Amit Surve, Daniel Cottam, Hinali Zaveri, et al.
Blood
|
December 7, 2007
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Roberto Piva, Bruce Ruggeri, Michael Williams, et al.
Annals of Epidemiology
|
February 17, 2021
Differences in rapid increases in county-level COVID-19 incidence by implementation of statewide closures and mask mandates - United States, June 1-September 30, 2020
Sharoda Dasgupta, Ahmed M Kassem, Gregory Sunshine, et al.
The British Journal of Surgery
|
April 25, 2024
Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort
Remon Korenblik, Jan Heil, Jens Smits, et al.
BMJ Open
|
June 16, 2023
What does high value care for musculoskeletal conditions mean and how do you apply it in practice? A consensus statement from a research network of physiotherapists in New South Wales, Australia
Connor Gleadhill, Katherine Dooley, Steven J Kamper, et al.
Journal of Medicinal Chemistry
|
December 16, 2011
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E
Martin W Rowbottom, Raffaella Faraoni, Qi Chao, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 394) with videos related to
Sort By:
Page
of 40
The British Journal of Ophthalmology
|
August 7, 2019
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study
Richard P Gale, Ian Pearce, Nicole Eter, et al.
Molecular Cancer Therapeutics
|
February 10, 2012
CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity
Joyce James, Bruce Ruggeri, Robert C Armstrong, et al.
British Journal of Haematology
|
April 19, 2017
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma
Peter Martin, Zhengming Chen, Bruce D Cheson, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
August 9, 2005
Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study
Constantine G Lyketsos, Leslie Toone, JoAnn Tschanz, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
September 2, 2018
Does the future of laparoscopic sleeve gastrectomy lie in the outpatient surgery center? A retrospective study of the safety of 3162 outpatient sleeve gastrectomies
Amit Surve, Daniel Cottam, Hinali Zaveri, et al.
Blood
|
December 7, 2007
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Roberto Piva, Bruce Ruggeri, Michael Williams, et al.
Annals of Epidemiology
|
February 17, 2021
Differences in rapid increases in county-level COVID-19 incidence by implementation of statewide closures and mask mandates - United States, June 1-September 30, 2020
Sharoda Dasgupta, Ahmed M Kassem, Gregory Sunshine, et al.
The British Journal of Surgery
|
April 25, 2024
Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort
Remon Korenblik, Jan Heil, Jens Smits, et al.
BMJ Open
|
June 16, 2023
What does high value care for musculoskeletal conditions mean and how do you apply it in practice? A consensus statement from a research network of physiotherapists in New South Wales, Australia
Connor Gleadhill, Katherine Dooley, Steven J Kamper, et al.
Journal of Medicinal Chemistry
|
December 16, 2011
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E
Martin W Rowbottom, Raffaella Faraoni, Qi Chao, et al.
Page
of 40